Article
A distinct innate immune signature marks progression from mild to severe COVID-19
25 Dec 2020
Abstract excerpt
Coronavirus disease 2019 (COVID-19) manifests with a range of severities, but immune signatures of mild and severe disease are still not fully understood. Here, we use mass cytometry and targeted proteomics to profile the innate immune response of patients with mild or severe COVID-19 and of healthy individuals. Sampling at different stages allows us to reconstruct a pseudo-temporal trajectory of the innate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
